Copyright
©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 102078
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.102078
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.102078
Table 1 Baseline characteristics in a cohort of extracorporeal membrane oxygenation patients with direct vs consultative primary advanced heart failure and transplant involvement, n (%)
Total (n = 51) | With direct AHFTC role (n = 21) | With consultative AHFTC role (n = 30) | P value | |
Age (year) | 47.2 (SD 14.5) | 47.0 (SD 13.3) | 47.4 (SD 15.5) | 0.92 |
RESP score | 3.4 (SD 3.3) | 3.2 (SD 1.9) | 3.5 (SD 4.1) | 0.81 |
SAVE score | -5.7 (SD 3.9) | -4.6 (SD 4.3) | -6.5 (SD 3.5) | 0.22 |
Time on ECMO (days) | 11.8 (SD 17.3) | 15.6 (SD 21.8) | 9.3 (SD 13.3) | 0.21 |
Total days of MV prior to cannulation (days) | 3.6 (SD 5.2) | 3.0 (SD 3.6) | 4.0 (SD 6.0) | 0.51 |
Renal function | 2.1 (SD 1.7) | 1.9 (SD 1.8) | 2.1 (SD 1.7) | 0.68 |
On pressors | 44 (86) | 15 (71) | 29 (97) | 0.01 |
Requiring RRT | 23 (45) | 5 (24) | 18 (60) | 0.01 |
Requiring mechanical ventilation | 49 (96) | 19 (90) | 30(100) | 0.09 |
Requiring tMCS | 15 (29) | 5 (24) | 10 (33) | 0.46 |
With Swan-ganz placement | 20 (39) | 9 (43) | 11 (37) | 0.66 |
Table 2 Comparison of survival outcomes in a cohort of extracorporeal membrane oxygenation patients with direct vs consultative advanced heart failure and transplant involvement
Total (n = 51) | With direct AHFTC role (n = 21) | With consultative AHFTC role (n = 30) | Unadjusted odds ratio | P value | Adjusted odds ratio1 | P value | |
Total survival after decannulation (%) | 32/51 (63) | 15/21 (71) | 17/30 (57) | 1.6 (0.5-5.6) | 0.46 | 1.6 (0.4-5.6) | 0.49 |
Total survival to 30 days post discharge (%) | 23/51 (45) | 14/21 (67) | 9/30 (30) | 4.7 (1.4-15) | 0.01 | 5.3 (1.5-19) | 0.01 |
VA survival after decannulation (%) | 17/26 (65) | 8/11 (73) | 9/15 (60) | 2.25 (0.4-14.6) | 0.40 | 2.20 (0.3-16) | 0.43 |
VA survival to 30 days post discharge (%) | 10/26 (38) | 7/11 (64) | 3/15 (20) | 7.0 (1.2-40.8) | 0.03 | 6.4 (1.0-41.7) | 0.05 |
VV survival after decannulation. (%) | 15/25 (60) | 7/10 (70) | 8/15 (53) | 1.7 (0.6-5.9) | 0.43 | 1.8 (0.7-6.1) | 0.45 |
VV survival to 30 days post discharge (%) | 13/25 (52) | 7/10 (70) | 6/15 (40) | 3.5 (0.6-19.2) | 0.15 | 4.8 (0.71-32.2) | 0.11 |
- Citation: Zhang J, Nagamine T, Vu K, Ali M, Limpruttidham N, Gozun M, Moreno JP, Banerjee D. Comparison of a direct vs consultative advanced heart failure role in the outcomes of extracorporeal membrane oxygenation patients. World J Transplant 2025; 15(3): 102078
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/102078.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.102078